CLIA articles & resources on Made-in-China.com

China's Cruise Market Will Continue to Grow

Apr 13, 2015

With the rise of the Chinese middle class, the nation's cruise market will continue to grow, and is expected to become the Asia's largest market by 2020, industry sources said. Data recently released by the Cruise Lines International ...

Tags: Cruise market, Cruise ships

CareDx Intends to Make an IPO of Common Stock with The Intent of Realizing $50 Million.

Jun 13, 2014

CareDx. which two weeks ago entered into an agreement to acquire ImmuMetrix Inc., has announced that it intends to make an initial public offering (IPO) of common stock with the intent of realizing $50 million. Brisbane, CA–based ...

Tags: Health, Medicine

ResearchDx,LLC of Irvine,California,USA Today Announced an Expansion of Its Operations

Feb 11, 2014

ResearchDx,LLC of Irvine,California,USA today announced an expansion of its operations to focus on the important Middle East clinical laboratory and diagnostics markets. As part of this initiative,ResearchDx will be exhibiting at the 2014 ...

Tags: ResearchDx, Diagnostics Organization, health

Researchdx Expands Operations to Focus on The Middle East

Feb 10, 2014

US-based ResearchDx has announced an expansion of its operations to focus on the important Middle East clinical laboratory and diagnostics markets. As part of this initiative,ResearchDx will be exhibiting at the 2014 Arab Health Congress ...

Tags: accreditations, Researchdx, Arab Health Congress

Sapio Sciences Is Pleased to Announce The Release of Exemplar NGS LIMS

Jan 20, 2014

Sapio Sciences is pleased to announce the release of Exemplar NGS LIMS™. Sapio's NGS LIMS system will track multiple next-generation sequencing (NGS) platform workflows from request through processing and analysis. Sapio has gained ...

Tags: Health, Medicine

NYSDOH Conditional Approval for Rosetta Kidney Cancer Test Is Resched by Rosetta Genomics

Dec 11, 2013

Rosetta Genomics, a provider of microRNA-based molecular diagnostics, has obtained a conditional approval from the New York State Department of Health (NYSDOH) for its Rosetta Kidney Cancer Test for testing on patient samples from the ...

Tags: Rosetta Kidney Cancer, Medicine

NanoString Announced The Availability of The Ncounter Dx Analysis System

Nov 14, 2013

NanoString Technologies, a provider of life science tools for translational research and molecular diagnostic products, has announced the availability of the nCounter Dx analysis system for high-complexity, CLIA-certified laboratories. ...

Tags: NanoString, DX Analysis System

Pivotal Clinical Validation Study for 4kscore Test Were Commenced by OPKO

Nov 6, 2013

OPKO Health, a multinational pharmaceutical and diagnostics company, has commenced a pivotal, multi-center clinical validation study for the company’s 4Kscore test for the prediction of prostate cancer prior to prostate biopsy. The ...

Tags: OPKO Health, Medicine

Cancerplex for Genomic Testing of Cancer Was Launched by KEW

Oct 29, 2013

KEW Group, the oncology personalized medicine management and analytics company, has launched CancerPlex assay, a comprehensive gene testing panel that can be used to examine the genetic profile of many common cancers. Developed and ...

Tags: Genomic Testing, Medicine

Transgenomic Signed a Collaboration Agreement with PDI to Commercialize Its Cardiopredict

Oct 17, 2013

Global biotechnology company Transgenomic has signed a collaboration agreement with PDI, a health care commercialization company, to commercialize its CardioPredict. Developed by Transgenomic, CardioPredict identifies a patient's specific ...

Tags: Transgenomic, Commercializing Cardiopredict

510(K) Clearance for Prosigna Assay Is Obtained by Nanostring Technologies

Sep 12, 2013

NanoString Technologies, a provider of life science tools for translational research and molecular diagnostic products, has obtained the US Food and Drug Administration (FDA) 510(k) clearance for its Prosigna breast cancer prognostic gene ...

Tags: NanoString Technologies, Prosigna Assay

US FDA Categorized Cepheid's Xpert Mtb/Rif Test

Aug 30, 2013

The U.S. Food & Drug Administration (FDA) has categorized Cepheid's Xpert MTB/RIF test as 'moderate complexity' under the Clinical Laboratory Improvement Amendments (CLIA). Xpert MTB/RIF test is designed for the rapid molecular detection ...

Tags: moderate Complexity, Medicine

FDA Has Approved Alere's PMAfor Alere Determine HIV 1/2 AG/AB Combo

Aug 13, 2013

The US Food and Drug Administration (FDA) has approved Alere's pre-market application (PMA) for the commercialization of Alere Determine HIV 1/2 Ag/Ab Combo in the country. The FDA approval allows the marketing of Alere Determine HIV 1/2 ...

Tags: Alere Determine, Medicine

Quidel Received 510(K) Clearance From The US FDA

Aug 12, 2013

Quidel, a US-based virology assays and molecular diagnostic systems provider, has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Sofia hCG fluorescent immunoassay for use on the Sofia Analyzer. It is used ...

Tags: FDA Clearance, HCG Fluorescent

Trovagene Leverages Raindrop Platform Developed a Cell-Free DNA Mutation Assay Leveraging

Jul 31, 2013

Trovagene has adopted RainDance's RainDrop Digital PCR System for research and development, and for use in the Trovagene CLIA laboratory. In addition, Trovagene has successfully developed a cell-free DNA mutation assay leveraging the ...

Tags: Trovagene, Digital PCR System

CLIA

Related Products